Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -229 | 1,188 | 11,636 | -18,740 | -400 |
| Depreciation Amortization | 6,258 | 7,829 | 6,097 | 4,480 | 4,820 |
| Income taxes - deferred | -333 | -162 | -2,225 | N/A | N/A |
| Accounts receivable | 41 | -9,691 | -7,256 | N/A | N/A |
| Other Working Capital | -2,256 | -18,372 | -10,388 | -6,870 | 2,870 |
| Other Operating Activity | 730 | 10,561 | 7,712 | 4,880 | 6,640 |
| Operating Cash Flow | $4,211 | $-8,647 | $5,576 | $-16,250 | $13,930 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,218 | -10,913 | -5,133 | -16,150 | -15,330 |
| Net Acquisitions | 703 | -90 | -43 | 0 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1,540 |
| Investing Cash Flow | $-4,515 | $-11,003 | $-5,176 | $-16,150 | $-13,790 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 21,312 | 17,837 | 16,800 | N/A | N/A |
| Debt Repayment | -16 | -649 | N/A | N/A | N/A |
| Common Stock Issued | 750 | 563 | 832 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -800 | 0 |
| Other Financing Activity | -46,242 | -12,442 | -3,213 | 18,130 | 610 |
| Financing Cash Flow | $-24,196 | $5,309 | $14,419 | $17,330 | $610 |
| Exchange Rate Effect | -1,541 | -1,383 | 1,182 | 2,020 | 1,940 |
| Beginning Cash Position | 89,793 | 106,517 | 91,219 | 104,280 | 101,580 |
| End Cash Position | 63,834 | 91,293 | 106,517 | 91,240 | 104,280 |
| Net Cash Flow | $-25,959 | $-15,224 | $15,298 | $-13,040 | $2,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,211 | -8,647 | 5,576 | -16,250 | 13,930 |
| Capital Expenditure | -5,299 | -10,913 | -5,133 | N/A | N/A |
| Free Cash Flow | -1,088 | -19,560 | 443 | -16,250 | 13,930 |